Blog
RSS FeedPosted by Michael Wonder on 03 Dec 2022
AbbVie announces provincial reimbursement for Rinvoq (upadacitinib) for the treatment of rheumatoid arthritis and psoriatic arthritis in Alberta, New Brunswick, Ontario, Quebec and Saskatchewan
1 December 2022 - AbbVie today announced that Rinvoq is now listed as a special authorisation medication or exception medication status ...
Posted by Michael Wonder on 24 Oct 2022
Saskatchewan becomes sixth Canadian province to implement a biosimilar switching policy
21 October 2022 - Saskatchewan joined five provinces and one territory in implementing a biosimilar switching policy, allowing for reference ...
Posted by Michael Wonder on 28 Apr 2022
Baqsimi (nasal glucagon), rescue treatment for severe hypoglycaemia now covered in British Colombia, Alberta & Saskatchewan
27 April 2022 - Lilly Canada is pleased to announce that as of 5 April 2022, Baqsimi (glucagon nasal powder) ...
Posted by Michael Wonder on 02 Mar 2022
Teva Canada welcomes public drug plan reimbursement by Alberta, Saskatchewan, Québec, Veteran Affairs Canada and the non-insured health benefits program for patients prescribed Ajovy (fremanezumab) for the preventive treatment of migraine in adults
2 March 2022 - Public formulary and program coverage makes AJOVY® accessible to more migraine patients across Canada. ...
Posted by Michael Wonder on 11 Feb 2022
AbbVie announces first provincial reimbursements for Venclexta (venetoclax) in combination with azacitidine for acute myeloid leukaemia patients
10 February 2022 - Following the signing of an agreement between AbbVie and the pan-Canadian Pharmaceutical Alliance, Quebec, Saskatchewan, and ...
Posted by Michael Wonder on 08 Jun 2019
'Equity issue:' Saskatchewan to fully cover cost of abortion drug Mifegymiso
7 June 2019 - Advocates are celebrating the Saskatchewan government's decision to fully fund the cost of the abortion drug ...
Posted by Michael Wonder on 04 May 2019
'I took it for my family': Accepting risks of multiple sclerosis drug a part of Sask. couple's love story
3 May 2019 - Sask. just announced it will fund a drug that may relieve rapid degeneration caused by MS. ...
Posted by Michael Wonder on 02 May 2019
SMA patients in Saskatchewan, Canada, gain wider access to Spinraza
1 May 2019 - The Canadian province of Saskatchewan has joined that of Quebec in granting access to Spinraza (nusinersen) ...
Posted by Michael Wonder on 07 Aug 2017
Sask. woman calls on government to cover cystic fibrosis drug
4 August 2017 - A Beauval, Sask. woman wants the Canadian government to cover an expensive drug for her cystic ...
Posted by Michael Wonder on 19 Jan 2017
Canada reaches health funding agreement with Saskatchewan
17 January 2017 - Canada's public healthcare system is a source of pride. The Government of Canada and the Government ...
Posted by Michael Wonder on 06 Jul 2016
Saskatchewan includes Lemtrada (alemtuzumab) on MS Drugs Program for eligible patients
5 July 2016 - Unique treatment delivered in only two cycles one year apart. ...